Healthcare provider profile · identity verified

Yordan Jimenez Perez

Internal Medicine · ORLANDO, FL · NPI 1356801492

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	577	203
Rosuvastatin Calcium	Rosuvastatin Calcium	513	191
Amlodipine Besylate	Amlodipine Besylate	334	136
Losartan Potassium	Losartan Potassium	319	108
Lisinopril	Lisinopril	314	111
Metformin Hcl	Metformin Hcl	302	112
Diclofenac Sodium	Diclofenac Sodium	275	158
Levothyroxine Sodium	Levothyroxine Sodium	267	91
Gabapentin	Gabapentin	211	91
Glipizide	Glipizide	186	65
Pantoprazole Sodium	Pantoprazole Sodium	176	84
Ozempic	Semaglutide	170	39
Omeprazole	Omeprazole	168	79
Metoprolol Succinate	Metoprolol Succinate	157	55
Furosemide	Furosemide	150	60
Fluticasone Propionate	Fluticasone Propionate	148	110
Vitamin D2	Ergocalciferol (Vitamin D2)	133	94
Hydrochlorothiazide	Hydrochlorothiazide	131	51
Metoprolol Tartrate	Metoprolol Tartrate	126	53
Albuterol Sulfate Hfa	Albuterol Sulfate	124	70
Carvedilol	Carvedilol	118	47
Alendronate Sodium	Alendronate Sodium	110	46
Famotidine	Famotidine	102	50
Eliquis	Apixaban	97	32
Tamsulosin Hcl	Tamsulosin Hcl	96	45
Trazodone Hcl	Trazodone Hcl	95	46
Azithromycin	Azithromycin	86	67
Tizanidine Hcl	Tizanidine Hcl	85	51
Meclizine Hcl	Meclizine Hcl	76	45
Triamcinolone Acetonide	Triamcinolone Acetonide	75	48
Baclofen	Baclofen	73	50
Simvastatin	Simvastatin	73	28
Ezetimibe	Ezetimibe	71	28
Montelukast Sodium	Montelukast Sodium	69	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	23
Prednisone	Prednisone	64	38
Farxiga	Dapagliflozin Propanediol	55	15
Methylprednisolone	Methylprednisolone	53	45
Sildenafil Citrate	Sildenafil Citrate	52	12
Irbesartan	Irbesartan	51	16
Hydralazine Hcl	Hydralazine Hcl	50	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	17
Pravastatin Sodium	Pravastatin Sodium	49	17
Glimepiride	Glimepiride	47	17
Escitalopram Oxalate	Escitalopram Oxalate	46	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	15
Metformin Hcl Er	Metformin Hcl	44	18
Pioglitazone Hcl	Pioglitazone Hcl	44	13
Clopidogrel	Clopidogrel Bisulfate	43	19
Jardiance	Empagliflozin	43	12
Azelastine Hcl	Azelastine Hcl	40	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	30
Duloxetine Hcl	Duloxetine Hcl	33	18
Enalapril Maleate	Enalapril Maleate	33	suppressed
Mupirocin	Mupirocin	33	24
Doxycycline Monohydrate	Doxycycline Monohydrate	31	27
Finasteride	Finasteride	31	14
Ibuprofen	Ibuprofen	31	25
Memantine Hcl	Memantine Hcl	31	13
Mirtazapine	Mirtazapine	31	14
Trulicity	Dulaglutide	30	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	17
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	26
Allopurinol	Allopurinol	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	16
Naproxen	Naproxen	27	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	16
Januvia	Sitagliptin Phosphate	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Potassium Chloride	Potassium Chloride	25	11
Sertraline Hcl	Sertraline Hcl	25	11
Valsartan	Valsartan	25	suppressed
Ketoconazole	Ketoconazole	24	16
Fenofibrate	Fenofibrate	22	suppressed
Latanoprost	Latanoprost	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Synthroid	Levothyroxine Sodium	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	18
Dicyclomine Hcl	Dicyclomine Hcl	19	11
Meloxicam	Meloxicam	19	13
Nifedipine Er	Nifedipine	19	suppressed
Nitroglycerin	Nitroglycerin	19	17
Novolog Flexpen	Insulin Aspart	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	17
Cephalexin	Cephalexin	18	16
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	11
Chlorthalidone	Chlorthalidone	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Lactulose	Lactulose	17	suppressed
Methocarbamol	Methocarbamol	17	12
Sucralfate	Sucralfate	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Linzess	Linaclotide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	13	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Ondansetron Odt	Ondansetron	12	11
Repatha Sureclick	Evolocumab	12	suppressed
Folic Acid	Folic Acid	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error